Media

Join our Chief Product Officer, Eric Malis for another in-depth webinar on Nitazines, a potent and emerging class of synthetic opioids. We’ll explore current trends in Nitazine usage, the challenges in detecting and testing for these substances, and the latest screening methods, as well as, the significant threat they pose to public health. This session is crucial for healthcare professionals and policymakers to understand the growing impact of Nitazines and develop effective strategies to address the rise in use. Watch the full recorded live webinar now.

In this live recorded webinar, we delve into the pressing topic of Fentanyl, other Opioids, usage, myths and the current state of the ongoing opioid crisis. Our Chief Product Officer, Eric Malis, will provide insights into these substances, including their impact on public health, trends in usage, regulatory measures, and innovative approaches to address the crisis. From the latest statistics to potential solutions, this webinar promises a comprehensive exploration of one of today’s most urgent public health challenges.

In this insightful live recorded webinar, we delve into the world of hallucinogens from a point of care toxicology testing standpoint. We will explore various types of hallucinogens, their effects on the mind and body, and the challenges they present in regard to toxicology screening. Our Chief Product Officer, Eric Malis, will discuss current testing methods, limitations, and future advancements in this field. Whether you’re a healthcare professional, researcher, or simply have an interest in the subject, this webinar promises to provide valuable knowledge and perspective.

Chief Product Officer, Eric Malis, discusses Opiates and Opioids and the differences between them. Often the two are thought to be one in the same but there is important information you need to know about what makes them different and what that means from a drug testing stand point.

Benzodiazepines, most commonly known as the prescription drugs, Xanax®, Valium®, Halcion®, Ativan® and Klonopin®, can be very helpful to those who need it. Unfortunately this medication has a high risk of dependency and can lead to abuse. Join our Chief Product Officer, Eric Malis, for another LIVE  recorded educational webinar about the commonly prescribed yet commonly abused depressant. Learn about the importance and dangers of Benzodiazepine and how and why you should be testing for it.

Most of us have probably heard something in the news about Xylazine. The powerful veterinary sedative and anesthetic, often referred to as “Tranq” on the street, is becoming more commonly abused across the US. In this recorded live session, Chief Product Officer, Eric Malis, will talk about why this is important, things you should know, and what you can do to detect use and help fight this new emerging threat. 

The state of designer opioids is an ever changing landscape. When it comes to powerful street drugs such as designer opioids it is important to understand what is being produced and what to look out for. Chief Product Officer takes a deep dive into understanding current trends of designer opioids.

In the latest NTS-U Webinar, join Chief Product Office, Eric Malis in discussing drugs of abuse commonly found at gas stations, convenience stores, and smoke shops; most of which are in legal gray areas.